Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction Trial.
Atsushi TadaDaniel BurkhoffJwan A NaserTomonari HaradaBianca PourmussaYogesh N V ReddyMichael D JensenRickey E CarterRyan T DemmerJeffrey M TestaniJulio Alonso ChirinosBarry A BorlaugPublished in: Circulation (2024)
URL: https://www.clinicaltrials.gov; Unique identifier: NCT04730947.